期刊文献+

利血平增敏法检测恩诺沙星药物残留的研究

Study On the Activities of enrofloxacin against Staphylococcus aureus and the Effect of Reserpine on These Activities
下载PDF
导出
摘要 目的了解恩诺沙星对金黄色葡萄球菌(金葡菌)的抗菌活性及利血平对其抗菌活性的影响。方法采用对倍稀释浓度琼脂平板法测定抗菌药物的最低抑菌浓度(MIC)值,同法测定利血平对恩诺沙星对金葡菌MIC值的影响。结果利血平可有效增强恩诺沙星的抗菌活性,增大了恩诺沙星抑制金葡菌的抑菌圈直径,提高了恩诺沙星在组织中检测的灵敏度。研究发现利血平加入后中心浓度由0.5ul/ml变为0.0625ul/ml,最低检测限由0.125μg/ml降低到0.015625μg/ml。最低检测限减低了8倍。 Objective To investigate the activities of enrofloxacin and the effects of reserpine on the activities of enrofloxacin against Staphylococcus aureus. Methods The minimal inhibitory concentration (M1Cs)and the effects of reserpine on MICs of enrofloxacin against Staphylococcus aureus were determined using standard agar dilution method. Results Antibacterial activity of enrofloxacin was effectively strengthened by reserpine, inhibition zone of Staphylococcus aureus was enlarged by enrofloxacin. The test sensitivity was increased in tissnes. The investigation indicated that the central concentration was converted from 0.5ul/ml to 0.0625ul/ml and detection limit converted from 0.125ug/ml to 0.015625ug/ml after adding reserpine, detection limit was reduced by 8 times.
出处 《中国动物检疫》 CAS 北大核心 2008年第11期28-31,共4页 China Animal Health Inspection
基金 "十一五"国家支撑项目(2006BAK02A08-4) 安徽省"十五"科技重大攻关项目(0400303041) 安徽省优秀青年基金(04041042)。
关键词 恩诺沙星 金黄色葡萄球菌 利血平 抗菌活性 Enrofloxacin Staphylococcus aureus Reserpine Antibacterial activity
  • 相关文献

参考文献15

  • 1Gee H E, Ho K B ,Toothill J .Liquid chromatographic determination of benzylpenicillin and eloxaeillin in animal tissues and its application to a study of the stability at 20 degrees of spiked and incurred residues of benzylpenicillin in ovine liver [J].J AOAC lnt, 1996,79(3) : 640-644. 被引量:1
  • 2Brady M S,Katz S E.Simplified plate difu- sion system for microbial assays of antibiotics [J].J AOAC, 1987,70(4) :641-646. 被引量:1
  • 3Koenen-Dieriek K,Okerman L,de Zutter L,et al.A one-plate microbiological screening test for antibiotic residue testing in kidney tissue and meat:an alternative to the EEC four-plate method [J].Food Addit Contam, 1995,19(1) :77-82. 被引量:1
  • 4Van Dresser W R ,Wileke J R.Drug residues in food animals [J]. Am Vet Med Assoc, 1989, 194 (12) : 1700-1710. 被引量:1
  • 5Varma M V S,Ashokraj Y,Dey C S,et al.Pglycoprotein inhibitors and their screening:a perspective from bioavailability enhancement [J]. Pharm Res, 2003,48(4) : 347-359. 被引量:1
  • 6刘传爱,何汉江,谭立志,李丽华,周芸,姚艳冰,方会龙.主动外排抑制剂对耐氟喹诺酮的表皮葡萄球菌MIC的影响[J].实用预防医学,2005,12(3):533-535. 被引量:3
  • 7张能江.金黄色葡萄球菌的多重耐药转运蛋白NorA[J].国外医药(抗生素分册),2001,22(4):165-167. 被引量:5
  • 8Piddock I. New qunolones and gram-positive bacteria [J].Antimicrob Agents Chemother, 1994,38 : 163. 被引量:1
  • 9Hori S,Yoshihiro O,Utsui Y,et al. Sequential acquisition of norfloxacin and ofloxacin resistance by methucillin-resistant and-susceptible Staphylococcus [J].Antimicrob Agents Chemother, 1993,37 : 2567. 被引量:1
  • 10Yamamoto ,Takubo S ,Fujita K,et al.Cloning and restriction analysis of DNA conferring new antimicroobial agent resistance from Staphylococcus aureus and other negative Staphylococcus species[J].FEMS Microbiol Lett. 1990,68 : 335. 被引量:1

二级参考文献33

  • 1王海燕,荒井雅吉,供田洋,大村智.微生物来源的Azole类抗真菌活性增强剂——FKI-0076A、B和C的研究[J].中国抗生素杂志,2001,26(2):89-93. 被引量:4
  • 2[1]Ubukata K, Itoh NY, Konno M, et al. Cloning and expression of the norA gene for fluoroquinolone resistance in Staphylococcus aureus. [J]. Antimicrob Agents Chemother, 1989, 33(9): 1535 被引量:1
  • 3[2]Yoshida H, Bogaki M, Nakamura S, et al. Nucleotide sequence and characterization of the Staphylococcus aureus norA gene, which confers resistance to quinolones. [J]. J Bacteriol,1990, 172(12): 6942 被引量:1
  • 4[3]Kaatz GW, Seo SM, Ruble CA, et al. Efflux-mediated fluoroquinolone resistance in Staphylococcus aureus. [J].Antimicrob Agents Chemother, 1993, 37(5): 1086 被引量:1
  • 5[4]Sierra JM, Ruiz J, Jimenez DMT, et al. Prevalence of two different genes encoding NorA in 23 clinical strains of Staphylococcus aureus. [J]. J Antimicrob Chemother,2000, 46(1): 145 被引量:1
  • 6[5]Ng EYW, Trucksis M, Hooper DC. Quinolone resistance mediated by norA: physiologic characterization and relationship to flqB, a quinolone resistance locus on the Staphylococcus aureus chromosome. [J]. Antimicrob Agents Chemother, 1994, 38(6): 1345 被引量:1
  • 7[6]Fournier B, Aras R, Hooper DC. Expression of the multidrug resistance transporter NorA from Staphylococcus aureus is modified by a two-component regulatory system.[J]. J Bacteriol, 2000, 182(3): 664 被引量:1
  • 8[7]Kaatz GW, Seo SM. Inducible NorA-mediated multidrug resistance in Staphylococcus aureus. [J]. Antimicrob Agents Chemother, 1995, 39(12): 2650 被引量:1
  • 9[8]Munoz-Bellido JL, Alonso MM, Martinez JA, et al. Efflux pump-mediated quinolone resistance in Staphylococcus aureus strains wild type for gyrA, gyrB, grlA and norA.[J]. Antimicrob Agents Chemother, 1999, 43(2): 354 被引量:1
  • 10[9]Kaatz GW, Seo SM, Foster TJ. Intriduction of a norA promoter region mutation into the chromosome of a fluoroquinolone-susceptible strain of Staphylococcus aureus using plasmid intergration. [J ]. Antimicrob Agents Chemother, 1999, 43(9): 2222 被引量:1

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部